Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis

A R Exley ¹, T Leese , M P Holliday

⁰Department of Bacteriology, Hammersmith Hospital, London.

Gut +

|

August 1, 1992

View abstract on PubMed

Summary

Endotoxemia and tumor necrosis factor are linked to poor outcomes in severe acute pancreatitis. Higher levels of these markers indicate a worse prognosis and increased mortality risk in patients.

Area Of Science

Biochemistry
Immunology
Gastroenterology

Background

Severe sepsis and septic shock involve endotoxemia and tumor necrosis factor (TNF).
Acute pancreatitis shares clinical and pathological similarities with septic shock.
Identifying prognostic factors in severe acute pancreatitis is crucial for patient management.

Purpose Of The Study

To investigate endotoxemia and TNF as prognostic factors in severe acute pancreatitis.
To correlate endotoxin and TNF levels with patient outcomes, including mortality.

Main Methods

Studied 38 patients with prognostically severe acute pancreatitis.
Measured serum endotoxin and TNF levels on day 1 of admission.
Analyzed the correlation between biomarker levels and clinical outcomes (severity, mortality).

Main Results

Endotoxemia was present in 51% of patients and significantly more common in non-survivors (91% vs. 35%).
Higher Day 1 serum endotoxin concentrations were associated with severe outcomes and mortality (p<0.01).
Day 1 serum TNF correlated with worse prognostic scores and severe outcomes (p<0.05), and mortality in gallstone pancreatitis (p=0.02).

Conclusions

Endotoxin and tumor necrosis factor show potential as prognostic biomarkers in severe acute pancreatitis.
These findings suggest a role for endotoxemia and TNF in the pathogenesis of severe acute pancreatitis.
Further research is warranted to confirm these prognostic implications.

Related Concept Videos